Literature DB >> 1675447

Correlation between magnetic resonance imaging and histopathology of intracranial glioma.

T Iwama1, H Yamada, N Sakai, T Andoh, T Nakashima, T Hirata, T Funakoshi.   

Abstract

Postmortem histopathology of eight gliomas was studied in correlation with magnetic resonance imaging (MRI) and computed tomography (CT) findings. MRI demonstrated the lesions more clearly and widely than CT. Also, T2-weighted images (T2WI) had a greater ability to depict the lesion than T1-weighted images (T1WI). The areas in which neoplastic cells had invaded corresponded to the high intensity areas on T2WI in four cases of glioblastoma multiforme. In the case of a grade II astrocytoma, neoplastic cells were scattered beyond the region corresponding to the high intensity area on T2WI. In the case of a grade III astrocytoma, neoplastic cells did not come up to the line corresponding to the margin of the high intensity area on T2WI. In the remaining two cases, although the high intensity areas on T2WI were depicted as being larger than the areas in which neoplastic cells were seen histopathologically, the high intensity regions corresponding to the outside zones of the tumour-infiltrated area were thought to be a radiation necrosis in one case and a 'periventricular high intensity' in the other. The high cellularity of the glioma was seen mainly as a low intensity area on T1WI and as an isointensity or a slightly high intensity area on T2WI. However, the signal intensities of glioma on MRI, reflecting T1 or T2 values of the tumour tissues, did not correlate with the malignancy of the tumour.

Entities:  

Mesh:

Year:  1991        PMID: 1675447     DOI: 10.1080/01616412.1991.11739964

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  11 in total

Review 1.  Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.

Authors:  Wolfgang Wick; Antje Wick; Markus Weiler; Michael Weller
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

2.  Cytotoxic T-cells as imaging probes for detecting glioma.

Authors:  Ali Syed Arbab
Journal:  World J Clin Oncol       Date:  2010-11-10

3.  The paradoxical effect of bevacizumab in the therapy of malignant gliomas.

Authors:  Eric M Thompson; Eugene P Frenkel; Edward A Neuwelt
Journal:  Neurology       Date:  2011-01-04       Impact factor: 9.910

4.  Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model.

Authors:  Danielle N Renner; Courtney S Malo; Fang Jin; Ian F Parney; Kevin D Pavelko; Aaron J Johnson
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

5.  Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab.

Authors:  Eric M Thompson; Edit Dosa; Dale F Kraemer; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2010-09-17       Impact factor: 4.130

Review 6.  Comparative aspects of neoplastic invasion of the brain.

Authors:  H E Kaiser
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.

Authors:  Ali S Arbab; Branislava Janic; Kourosh Jafari-Khouzani; A S M Iskander; Sanath Kumar; Nadimpalli R S Varma; Robert A Knight; Hamid Soltanian-Zadeh; Stephen L Brown; Joseph A Frank
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

8.  Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival.

Authors:  Rohan Ramakrishna; Jason Barber; Greg Kennedy; Adnan Rizvi; Robert Goodkin; Richard H Winn; George A Ojemann; Mitchel S Berger; Alexander M Spence; Robert C Rostomily
Journal:  Surg Neurol Int       Date:  2010-08-10

9.  Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas.

Authors:  Chloé Gerin; Johan Pallud; Christophe Deroulers; Pascale Varlet; Catherine Oppenheim; Francois-Xavier Roux; Fabrice Chrétien; Stephen R Thomas; Basile Grammaticos; Mathilde Badoual
Journal:  Neuro Oncol       Date:  2013-06-14       Impact factor: 12.300

10.  Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.

Authors:  Danielle N Renner; Fang Jin; Adam J Litterman; Alexis J Balgeman; Lisa M Hanson; Jeffrey D Gamez; Michael Chae; Brett L Carlson; Jann N Sarkaria; Ian F Parney; John R Ohlfest; Istvan Pirko; Kevin D Pavelko; Aaron J Johnson
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.